ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 1269

$443K Total Retail Price of All Prescriptions

Rank: 193 out of 1269

491 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 6,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 272 250 1 5
METOPROLOL TARTRATE 246 214 2 6
LEVOTHYROXINE SODIUM 227 221 3 4
TRAMADOL HCL 226 211 4 16
LISINOPRIL 221 183 5 1
WARFARIN SODIUM 140 120 6 12
METOPROLOL SUCCINATE 131 112 7 13
GABAPENTIN 129 111 8 17
MIRTAZAPINE 126 120 9 24
JANTOVEN 124 124 10 52
AMLODIPINE BESYLATE 122 101 11 2
METFORMIN HCL 112 92 12 9
PRAVASTATIN SODIUM 111 99 13 11
PREDNISONE 106 104 14 45
SIMVASTATIN 106 93 14 3
OMEPRAZOLE 86 76 16 8
ATENOLOL 84 84 17 14
KLOR-CON M20 81 69 18 60
PLAVIX 69 63 19 47
SERTRALINE HCL 69 61 19 23
TRAZODONE HCL 69 58 19 36
LACTULOSE 68 63 22 67
LANTUS 68 67 22 39
NYSTATIN 65 58 24 119
PAROXETINE HCL 63 53 25 71
LOVASTATIN 63 61 25 30
CITALOPRAM HBR 62 56 27 21
PANTOPRAZOLE SODIUM 62 60 27 18
ALLOPURINOL 61 57 29 49
ATORVASTATIN CALCIUM 59 55 30 7
DONEPEZIL HCL 58 58 31 22
QUETIAPINE FUMARATE 58 54 31 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 51 33 33
CLOPIDOGREL 57 56 33 32
LOSARTAN POTASSIUM 55 55 35 15
POTASSIUM CHLORIDE 54 46 36 26
CRESTOR 52 48 37 25
CARVEDILOL 51 46 38 29
LEVOFLOXACIN 51 47 38 75
CIPROFLOXACIN HCL 50 44 40 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.